Aardvark Therapeutics issued a press statement on February 27th announcing a pause in their HERO clinical trial of ARD-101 under development as a treatment for hyperphagia in PWS. The details are in their news release below.
The PWS community, and those in the HERO trial will be disappointed by the news, and IPWSO will relay any further information we receive.